Zynex announces 2021 third quarter earnings

Englewood, colo., nov. 2, 2021 /prnewswire/ -- 2021 third quarter revenue increased 74% year over year to $34.8 million orders increased 70% record net income of $6.1 million; diluted eps $0.17 adjusted ebitda $9.3 million zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its third quarter ended september 30, 2021.
ZYXI Ratings Summary
ZYXI Quant Ranking